A B S T R A C T Our recent observations of a complement-mediated, cell-independent mechanism of altered glomerular permeability in rat membranous nephropathy suggested a possible role for the terminal complement pathway in the mediation of proteinuria in certain forms of glomerular disease. To directly determine whether the membranolytic terminal complement components (C5b-C9) are involved in glomerular injury, we studied the development of proteinuria in normal and C6-deficient (C6D) rabbits, in both of which a membranous nephropathy-like lesion develops early in the course of immunization with cationized bovine serum albumin (cBSA) (pl 8.9-9.2). C6 hemolytic activity of C6D was 0.01% that of control rabbits. After 1 wk of daily intravenous injections of cBSA, proteinuria developed in 71% of controls (median 154, range 1-3,010 mg/24 h, n = 24), whereas none of C6D were proteinuric (median 6, range 2-12 mg/24 h, n = 12, P < 0.01). After 1 wk of cBSA, both groups had qualitatively identical glomerular deposits of BSA, rabbit IgG, and C3 on immunofluorescence microscopy, predominantly subepithelial electron-dense deposits on electron microscopy, and minimal glomerular inflammatory cell infiltration of glomeruli. Glomeruli were isolated from individual animals after 1 wk of cBSA
A B S T R A C T Our recent observations of a complement-mediated, cell-independent mechanism of altered glomerular permeability in rat membranous nephropathy suggested a possible role for the terminal complement pathway in the mediation of proteinuria in certain forms of glomerular disease. To directly determine whether the membranolytic terminal complement components (C5b-C9) are involved in glomerular injury, we studied the development of proteinuria in normal and C6-deficient (C6D) rabbits, in both of which a membranous nephropathy-like lesion develops early in the course of immunization with cationized bovine serum albumin (cBSA) (pl 8.9-9.2). C6 hemolytic activity of C6D was 0.01% that of control rabbits. After 1 wk of daily intravenous injections of cBSA, proteinuria developed in 71% of controls (median 154, range 1-3,010 mg/24 h, n = 24), whereas none of C6D were proteinuric (median 6, range 2-12 mg/24 h, n = 12, P < 0.01). After 1 wk of cBSA, both groups had qualitatively identical glomerular deposits of BSA, rabbit IgG, and C3 on immunofluorescence microscopy, predominantly subepithelial electron-dense deposits on electron microscopy, and minimal glomerular inflammatory cell infiltration of glomeruli. Glomeruli were isolated from individual animals after 1 wk of cBSA INTRODUCTION It has long been known that serum complement mediates tissue injury in the Arthus reaction (1) and heterologous phase of certain types of anti-glomerular basement membrane (GBM)l nephritis (2) through its leukocyte chemoattractant and immune adherent properties (3) . More recently, in two models of experimental membranous nephropathy, we observed a form of complement-mediated glomerular injury that occurred independently of any inflammatory infiltrate and in the face of selective neutropenia and pancytopenia (4, 5) . These observations, together with others demonstrating a cell-independent ameliorative effect of complement depletion on hyperacute cardiac allo-'Abbreviations used in this paper: ABC-33, antigen-binding capacity 33; cBSA, cationized bovine serum albumin; C6D, C6 deficient; DDW, distilled and deionized water; FxlA, proximal tubular epithelial cell brush border antigen; GBM, glomerular basement membrane; MAC, membrane attack complex of complement. graft rejection (6, 7) , suggested a hitherto undescribed role for complement in the mediation of tissue injury.
In addition to its inflammatory properties, for which C3b and C5a (3) are responsible, complement has a cytolytic action that is mediated by a cell membranebound complex of the terminal complement components, C5b-9, also known as the membrane attack complex (MAC) (8) . Immunofluorescence studies of tissue from patients with systemic lupus erythematosus (9, 10) , idiopathic membranous nephropathy and anti-GBM nephritis (11) have indicated the presence of the neoantigen of the MAC. Poly C9, a polymer of C9 that forms part of the MAC (12) , has also been found in glomerular lesions in patients with a variety of renal diseases (13) . While such findings support the hypothesis that the MAC is responsible for tissue injury, they by no means prove it.
Our previous studies on the cell-independent role of complement in glomerular injury were performed in the rat, which is the only species susceptible to the passive Heymann nephritis model of membranous nephropathy, but which lacks strains deficient in any of the terminal components of complement. To directly examine the role of terminal complement components in glomerular injury, we used the rabbit, a species in which a C6-deficient (C6D) strain exists, and in which a membranous nephropathy-like lesion develops early in the course of induction of chronic serum sickness with cationized bovine serum albumin (cBSA) (14) . These studies compare the early, noninflammatory phase of glomerular injury in normal and C6D rabbits and document a requirement for C6 in the development of proteinuria in this model. Since Quantitation of glomerular deposits of rabbit anti-BSA IgG. To determine the amount of rabbit IgG immunologically bound in the glomeruli of individual animals, the following procedure was used. The IgG fraction of sheep antirabbit IgG (heavy and light chains; Cappel Laboratories, Cochranville, PA) was radiolabeled with '25I (19, 20) . Specific activity was 9 X 104 cpm/Ag protein, of which 95% was precipitable with 10% trichloroacetic acid. The labeled IgG was stored at -70°C and was diluted with unlabeled IgG before use. Glomeruli were isolated by differential sieving, as previously described (20) , from the nonperfused kidneys of individual control (n = 6) and C6D (n = 5) rabbits after 1 wk of injections of cBSA, and a normal uninjected rabbit. After extensively washing the glomeruli with cold PBS, four test tubes of 2,000 glomeruli from each animal were incubated at 37°C for 48 h with 500, 1,000, 1,500, and 2,000 ,g of anti-rabbit IgG-'251 in a reaction volume of 1 ml of Hanks' balanced salt solution containing 2% human serum albumin, penicillin (25 To validate this method, identical conditions were used to assess the correlation between the binding of anti-rabbit IgG in vitro to rat glomeruli which contained subepithelial deposits of rabbit IgG, and the actual amount of rabbit IgG that had been immunologically planted in these glomeruli in vivo in the form of antibody to rat proximal tubular epithelial cell brush border antigen (Fx1A). The IgG fraction of rabbit antirat FxLA was prepared and radiolabeled with 1311 exactly as described before (20) and was shown to produce granular capillary wall deposits of rabbit IgG by immunofluorescence and subepithelial electron-dense deposits typical of passive Heymann nephritis (22 In addition, a high degree of penetration of glomeruli by anti-rabbit IgG in vitro is demonstrated by the binding ratio of 12:1 (slope of the line) and a very small amount of nonspecific binding is indicated by the fact that the y intercept passes close to the origin (Fig. 1) .
Tissue processing and immunofluorescence procedures.
Tissue for light microscopy was fixed in 10% neutral buffered formalin, sectioned at 4jim, and stained with hematoxylin and eosin and periodic acid-Schiff reagent.
Direct immunofluorescence procedures were performed on renal tissues snap frozen in dry ice-isopentane, sectioned at 4 jm in a cryostat, and fixed in ether-alcohol as previously described (22 gel electrophoresis showed that the cationization process caused very little polymerization of the cBSA. Specific C6 hemolytic activity in C6D rabbits was 6±0.8 CH50 units/ml, which represents 0.01% of C6 activity in control rabbits (60,000±14,140 CH50 units/ ml). C3 levels in the C6D rabbits were 121±34% of pooled, control rabbit sera by radial immunodiffusion. Anti-BSA antibodies were measured in the serum of both groups by ABC-33 using 0.2 ug BSA as antigen. After 1 wk of daily cBSA, serum from control rabbits precipitated 6.5-99.0 MAg BSA/ml (median 32.0, n = 14) and serum from C6D rabbits precipitated 2.0-46.9 ,g BSA/ml (median 17.2, n = 13). Although the difference reached statistical significance (P = 0.05), there was considerable overlap between animals in the two groups. Serum creatinine did not change in any of the animals and after 1 wk of cBSA injections, it was 1.2±0.4 mg/dl in control and 1.1±0.4 mg/dl in C6D rabbits.
The results of 24-h urine protein excretion in control and C6D rabbits after 1 wk of daily cBSA are shown in Fig. 2 . 24-h urine protein excretion exceeded the normal upper 99% confidence limit of 18 mg/24 h in 71% of controls (median 154, range 1-3,010 mg/24 h, n = 24), whereas none of the C6D rabbits were proteinuric (median 6, range 2-12 mg/24 h, n = 12, P < 0.01). In control rabbits there was a rough linear correlation between the serum anti-BSA levels, as measured by ABC-33, and the log urine protein excretion at 1 wk (log y = 0.0233 x + 0.8311, n = 14, r = 0.58, P < 0.05), which predicts that all animals with ABC- More direct evidence that the difference in proteinuria at 1 wk between controls and C6D rabbits was not the result of quantitative differences in glomerular antibody deposition at 1 wk is presented in Fig. 3 Glomerular immune deposits in the two groups were also found to be qualitatively similar by immunofluorescent and electron microscopy. Fig. 4 demonstrates the similarity in glomerular capillary wall deposits of rabbit IgG and C3 in control (Fig. 4 , a and c) and C6D rabbits (Fig. 4, b and d) . IgG deposition at 1 wk was linear-granular in appearance and followed a peripheral capillary loop pattern (Fig. 4, a and b) . With time, the granularity of IgG deposits became more apparent. At 1 wk, C3 was deposited in a granular, segmental pattern occupying peripheral capillary loops and mesangium (Fig. 4, c and d ). With time, C3 deposits increased in intensity in both groups and involved peripheral capillary walls more diffusely. At 1 wk, BSA deposition was similar in both groups with a linear-granular appearance. Electron microscopy of glomeruli was identical in control (Fig. 5 a) and C6D rabbits (Fig. 5 b) , and showed small, predominantly subepithelial, and occasional subendothelial, electron-dense deposits. Glomerular morphology was well preserved and epithelial foot processes were intact in both groups (Fig.  5, a and b) . Occasional mononuclear and polymorphonuclear leukocytes were noted in the glomerular capillary lumena of both groups at 1 wk. Light microscopy revealed a minimal increase in glomerular cellularity in both groups at 1 wk (Fig. 6, a and b) . Glomerular morphology was otherwise normal.
Results after 2 wk of cBSA injection. After 2 wk of daily injections of cBSA, light and electron microscopy showed marked hypercellularity of the glomeruli of both groups due to the infiltration of polymorphonuclear leukocytes and mononuclear cells. Subepithelial deposits were much larger and more flocculent than at 1 wk and epithelial foot processes showed extensive effacement in both groups. Intense, granular, peripheral capillary deposits of rabbit IgG and C3 were detected by immunofluorescence. Coincident with the influx of inflammatory cells at 2 wk, C6D rabbits became proteinuric (median 421, range 156-878 mg/24 h, n = 6) so that they no longer differed significantly from the control group (median 359, range 13-4,451 mg/24 h; P > 0.05).
DISCUSSION
The aim of these studies was to examine the role of complement, in particular the terminal complement pathway, in the genesis of immune injury during the early, noninflammatory phase of serum sickness induced by cBSA in rabbits. During this early phase, immune deposits are predominantly subepithelial, glomerular morphology is normal, and inflammatory cell infiltration is minimal. The results of these studies show that proteinuria develops in the majority of normal rabbits during this phase of injury, whereas proteinuria is completely absent in C6D rabbits, despite qualitatively and quantitatively similar glomerular antibody and C3 deposits. Since the only established function of C6 is in the assembly of the MAC (8, 24) , these findings strongly suggest that complement can produce glomerular injury in a manner analogous to its cytolytic effect (25) .
These results are consistent with our earlier observations on a cell-independent form of complementmediated, immunologic glomerular injury in rat membranous nephropathy (4, 5) but, in addition, indicate the probable mechanism of such injury. It has long been recognized that the development of proteinuria in rats immunized with a fraction of Fx1A to produce Heymann nephritis, corresponds with the presence of complement deposits in glomeruli (Noble, B., personal communication; and reference 26). By depleting rats of complement with cobra venom factor, we demonstrated the essential role for complement in the genesis of proteinuria and showed that only the complementfixing, yl subclass of sheep anti-FxlA IgG was capable of altering glomerular permeability (4 iF '4 5ib .ba FIGURE 5 Electron micrographs of the glomerular capillary wall of control (a) and C6 deficient (b) rabbits after 1 wk of daily cBSA. The subepithelial layer of the basement membrane (BM) contains numerous, small electron densities (arrowheads), which are often located proximal to the filtration slit diaphragm. Epithelial cells (Ep) show normal interdigitating foot processes in both groups of animals. US, urinary space; End, endothelial cell; Cap, capillary lumen.
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pleted of complement or given the noncomplement-amount and distribution to rats given yi antibody but fixing, y2 subclass of sheep anti-Fx1A IgG developed did not become proteinuric (4 (22, 27, 28) and the other in which it is of exogenous origin (5, 29) , the complement-induced injury was found to be independent of inflammatory cells (4, 5) . A possible role for the membranolytic action of complement in glomerular injury was thus suggested but, until now, direct evidence was lacking. Analogous experimental observations have been made regarding the hyperacute rejection of cardiac grafts. Hyperacute rejection of cardiac allografts in presensitized rats was found to be ameliorated by complement depletion (7) and uninfluenced by neutrophil and platelet depletion (6, 30) , suggesting a direct effect of complement. Furthermore, hyperacute rejection of heart xenografts was delayed in C6D rabbits (31), indicating a possible cytolytic effect of complement in this form of immunologic vascular injury.
The current studies also add credence to recent observations that demonstrated, by immunofluorescence, the presence of the MAC neoantigen in glomerular deposits of patients with systemic lupus erythematosus (9), idiopathic membranous nephropathy, and anti-GBM nephritis (11) , and of polyC9 is a variety of glomerular lesions (13) . Since assembly of the MAC (32) and polymerization of C9 (12) inevitably follow the generation of C5 convertase by the classical and/or alternate pathways in the presence of an activating surface (8) , their mere presence in diseased glomeruli does not provide convincing proof of a pathogenetic role. Our current findings present direct evidence that C6, and by inference the MAC, is essential for the development of certain forms of glomerular injury. That these results were not due to impaired immune competence of C6D rabbits was demonstrated by the similar quantity and distribution of glomerular deposits of rabbit IgG in the two groups. In addition, glomerular deposits of rabbit C3 appeared as abundant in C6D as in control rabbits. While it is conceivable that glomerular immune deposits of some C6D rabbits with lower serum anti-BSA concentrations (and consequently higher free BSA levels) contained relatively more antigen than controls, there is no logical reason why this should have prevented them from becoming proteinuric. It is also unlikely that any disorder of leukocyte chemotaxis accounted for the lack of proteinuria in C6D rabbits since they have been shown to have normal chemotactic activity (24) . A contribution of the terminal complement sequence to coagulation is inferred from studies in which delayed in vitro clotting of C6D rabbit blood was observed in response to activators of the alternate complement pathway (33, 34) . While theoretically this clotting "defect" could have protected our C6D rabbits from glomerular injury (35) , it seems unlikely since there was no evidence of intraglomerular coagulation in our control group.
The cytolytic action of complement results from the insertion of the MAC, during its assembly, into the phospholipid bilayer of cell membranes. This leads to loss of the integrity of cell membranes due either to the formation of doughnut-shaped transmembrane channels (25) or to the loss and/or rearrangement of membrane phospholipids (36, 37) . Since the GBM does not contain phospholipid bilayers, it seems likely that the site of action of the MAC in glomerular injury is the plasma membrane of either the endothelial or epithelial cells or the slit diaphragms that bridge the space between adjacent epithelial cell foot processes. Altered capillary wall permeability might then arise as a result of impaired synthesis or repair of the GBM by endothelial or epithelial cells, or as a result of disruption of the slit diaphragm which, itself, may provide a final barrier to macromolecular filtration (38) . In this regard, it is of interest that recent studies have shown that the glomerular antigen responsible for subepithelial immune deposits in the Heymann models of rat membranous nephropathy is expressed on the surface of glomerular epithelial cell membranes (28, 39) . It was in the passive Heymann model (4) and its autologous phase (5) that we first detected a direct action of complement in glomerular injury.
One can only speculate on the actual mechanism of complement-mediated glomerular injury in the rabbit model used in these studies. Current evidence favors the hypothesis that glomerular immune deposits, in this model, form in situ after the initial localization of cBSA which interacts electrochemically with anionic sites in the glomerular capillary wall, and the subsequent binding of anti-BSA antibody and fixation of complement (14, 40, 41) . Antibody-induced complement fixation in the glomerular capillary wall would rapidly lead to assembly of the MAC which, because of the close proximity of the immune deposits to epithelial (and perhaps endothelial) cells, could become inserted into their plasma membranes and lead to cell damage. Closer scrutiny is required to determine whether the characteristic, doughnut-shaped MAC (25) can be visualized in the vicinity of glomerular immune deposits, or whether epithelial cells from such glomeruli exhibit alterations in the phospholipids of their plasma membranes (36, 37) .
The absence of inflammation, despite fixation of complement, in the early phase of injury in these studies might reflect the predominantly subepithelial location of immune deposits which renders them inaccessible to circulating neutrophils, as previously discussed (4, 5) . The subsequent appearance of proteinuria in C6D rabbits and its worsening in controls coincided with an intense inflammatory cell infiltrate and suggests the advent of a second, cell-dependent, form of injury. Whether or not the latter phase is dependent on the leukotactic (C5a) and immune adherent (C3b) properties of complement, as in the heterologous phase of anti-GBM nephritis (2, 3), remains to be resolved. In a similar model, in which in situ glomerular immune deposit formation was induced in rats with cationized human IgG, evidence was obtained for both cell-dependent and cell-independent forms of complementmediated injury (42) . It therefore seems likely that, in any form of antibody-induced tissue injury where immune deposits give rise to complement fixation, both cell-dependent and cytolytic forms of complement-mediated injury are potentially activated. The major determinant of which form predominates may be the site of immune deposition.
Thus, these results demonstrate, for the first time, that terminal complement components may mediate immunologic glomerular injury. They also provide a probable explanation of the mechanism of complementdependent, cell-independent proteinuria. These findings, and those in rat membranous nephropathy (4, 5), suggest a possible mechanism for the development of proteinuria in idiopathic membranous nephropathy in man in which a bland-appearing glomerular lesion is accompanied by a high prevalence of glomerular deposits of complement (11, 43) .
